|
GS172116: HP:0002457 Abnormal head movements
|
|
GS210158: GO:0006084 acetyl-CoA metabolic process
|
|
GS136290: morphine antinociception 2 (Morph2, Published QTL Chr 9)
|
|
GS135298: alcohol preference QTL 1 (Alpq1, Published QTL Chr 9)
|
|
GS136869: triglyceride QTL 1 (Trigq1, Published QTL Chr 9)
|
|
GS128223: Proteins found to be modified by at least two drugs of abuse
|
|
GS135716: dermititis 1 (Derm1, Published QTL Chr 9)
|
|
GS171644: HP:0011842 Abnormality of skeletal morphology
|
|
GS191059: GO:0030523 dihydrolipoamide S-acyltransferase activity
|
|
GS205780: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS190997: GO:0044281 small molecule metabolic process
|
|
GS136709: susceptibility to lung cancer 10 (Sluc10, Published QTL Chr 9)
|
|
GS135548: CD4 T cell subset 4 (Cd4ts4, Published QTL Chr 9)
|
|
GS135619: cholesterol 11 (Chol11, Published QTL Chr 9)
|
|
GS136812: type 2 diabetes modifying QTL 1 (Tdmq1, Published QTL Chr 9)
|
|
GS136117: body length 4 (Lgth4, Published QTL Chr 9)
|
|
GS1229: Differential gene expression among both the Heroin and Cocaine Abusers
|
|
GS199550: GO:0032787 monocarboxylic acid metabolic process
|
|
GS135354: BALB/c autoimmunity 1 (Baa1, Published QTL Chr 9)
|
|
GS136266: modifier of mammary tumor progression 3 (Mmtp3, Published QTL Chr 9)
|
|
GS176385: HP:0001249 Intellectual disability
|
|
GS33868: Striatum Gene expression correlates of Difference in distance traveled (cm) during the first last min (saline-ethanol) in Females BXD
|
|
GS199273: GO:0043233 organelle lumen
|
|
GS176107: HP:0000929 Abnormality of the skull
|
|
GS173995: HP:0000508 Ptosis
|
|
GS205788: GO:0044724 single-organism carbohydrate catabolic process
|
|
GS197594: GO:0006090 pyruvate metabolic process
|
|
GS200311: GO:0019216 regulation of lipid metabolic process
|
|
GS84213: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS177404: GO:0005737 cytoplasm
|
|
GS201251: GO:0044424 intracellular part
|
|
GS128598: Ethanol Induced Ataxia Chr#9
|
|
GS135351: Alzheimer's disease modifier 3 (Azdm3, Published QTL Chr 9)
|
|
GS182519: GO:0006732 coenzyme metabolic process
|
|
GS193215: GO:0006084 acetyl-CoA metabolic process
|
|
GS135647: cocaine induced activation 10 (Cocia10, Published QTL Chr 9)
|
|
GS193414: GO:0044249 cellular biosynthetic process
|
|
GS136500: proteoglycan induced arthritis 5 (Pgia5, Published QTL Chr 9)
|
|
GS202555: GO:0043436 oxoacid metabolic process
|
|
GS135527: castaneus 10 week body weight 2 (C10bw2, Published QTL Chr 9)
|
|
GS136938: vertebral trabecular bone trait 6 (Vtbt6, Published QTL Chr 9)
|
|
GS194890: GO:0004742 dihydrolipoyllysine-residue acetyltransferase activity
|
|
GS182752: GO:0032787 monocarboxylic acid metabolic process
|
|
GS208736: GO:0016746 transferase activity, transferring acyl groups
|
|
GS136556: protection against vaginal candidiasis 2 (Pvcan2, Published QTL Chr 9)
|
|
GS36237: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the center in Males BXD
|
|
GS176203: HP:0000478 Abnormality of the eye
|
|
GS172185: HP:0002977 Aplasia/Hypoplasia involving the central nervous system
|
|
GS136507: prion incubation determinant 2 (Pid2, Published QTL Chr 9)
|
|
GS135536: caffeine metabolism QTL 3 (Cafq3, Published QTL Chr 9)
|
|
GS181430: GO:0006637 acyl-CoA metabolic process
|
|
GS173697: HP:0001319 Neonatal hypotonia
|
|
GS34792: Whole Brain Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in Females & Males BXD
|
|
GS177222: GO:0035384 thioester biosynthetic process
|
|
GS192299: GO:0006793 phosphorus metabolic process
|
|
GS198220: GO:0006637 acyl-CoA metabolic process
|
|
GS175390: HP:0011007 Age of onset
|
|
GS196808: GO:0032501 multicellular organismal process
|
|
GS186744: GO:0043226 organelle
|
|
GS182835: GO:0005622 intracellular
|
|
GS213074: Genes with suggestive difference in (B6PF1) vs (PB6F1 + B6 + PWD) comparison
|
|
GS83993: cocaine related behavior 9 (Cocrb9, Published QTL, Chr 9)
|
|
GS193942: GO:0035383 thioester metabolic process
|
|
GS209130: GO:0044704 single-organism reproductive behavior
|
|
GS84217: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS177704: GO:0051188 cofactor biosynthetic process
|
|
GS194778: GO:0042180 cellular ketone metabolic process
|
|
GS34381: Whole Brain Gene expression correlates of Novel environment locomotion (cm) 15-30 min in the center in Males BXD
|
|
GS34777: Whole Brain Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in Males BXD
|
|
GS209010: GO:1901575 organic substance catabolic process
|
|
GS126584: Tetrachlorodibenzodioxin interacting genes (MeSH:D013749) in CTD
|
|
GS175528: HP:0000007 Autosomal recessive inheritance
|
|
GS136644: serum IGFBP-5 level QTL 3 (Si5lq3, Published QTL Chr 9)
|
|
GS175526: HP:0000005 Mode of inheritance
|
|
GS196930: GO:0065007 biological regulation
|
|
GS171945: HP:0002268 Paroxysmal dystonia
|
|
GS201363: GO:0045254 pyruvate dehydrogenase complex
|
|
GS192512: GO:0003824 catalytic activity
|
|
GS197709: GO:0046365 monosaccharide catabolic process
|
|
GS208955: GO:0006006 glucose metabolic process
|
|
GS204746: GO:0080090 regulation of primary metabolic process
|
|
GS197244: GO:0044237 cellular metabolic process
|
|
GS136166: leishmaniasis resistance 2 (Lmr2, Published QTL Chr 9)
|
|
GS34371: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 15-30 min in the center in Males BXD
|
|
GS175529: HP:0000001 All
|
|
GS36442: Whole Brain Gene expression correlates of Open Field -Total distance in the perimeter in Females BXD
|
|
GS194138: GO:0005739 mitochondrion
|
|
GS176798: HP:0001266 Choreoathetosis
|
|
GS186740: GO:0043229 intracellular organelle
|
|
GS135675: cholesterol QTL 4 (Cq4, Published QTL Chr 9)
|
|
GS208012: GO:0044464 cell part
|
|
GS87380: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). (Whole Table) [DRG]
|
|
GS175407: HP:0002072 Chorea
|
|
GS136453: postnatal body weight growth 15 (Pbwg15, Published QTL Chr 9)
|
|
GS34401: Whole Brain Gene expression correlates of Novel environment rears 15-30 min in the center in Males BXD
|
|
GS192073: GO:1901576 organic substance biosynthetic process
|
|
GS188399: GO:0044238 primary metabolic process
|
|
GS136643: serum IGFBP-5 level QTL 2 (Si5lq2, Published QTL Chr 9)
|
|
GS135267: alopecia areata 2 (Alaa2, Published QTL Chr 9)
|
|
GS865: Sey_Pax6_Age_Reduced_Linear_Incr
|
|
GS201250: GO:0044429 mitochondrial part
|
|
GS204027: GO:0044708 single-organism behavior
|
|
GS176101: HP:0000924 Abnormality of the skeletal system
|
|
GS123718: Ethinyl Estradiol interacting genes (MeSH:D004997) in CTD
|
|
GS197577: GO:0016417 S-acyltransferase activity
|
|
GS193220: GO:0006082 organic acid metabolic process
|
|
GS127928: Lateral septal complex - Allen Mouse Brain Atlas
|
|
GS197016: GO:0032991 macromolecular complex
|
|
GS199635: GO:0005622 intracellular
|
|
GS197584: GO:0016418 S-acetyltransferase activity
|
|
GS174075: HP:0009121 Abnormal axial skeleton morphology
|
|
GS196941: GO:0008150 biological_process
|
|
GS123026: Haloperidol interacting genes (MeSH:D006220) in CTD
|
|
GS135322: APP associated premature death 1 (Appd1, Published QTL Chr 9)
|
|
GS175539: HP:0007256 Abnormality of pyramidal motor function
|
|
GS136547: periosteal circumference 6 (Pstc6, Published QTL Chr 9)
|
|
GS201256: GO:0044422 organelle part
|
|
GS201431: GO:0005515 protein binding
|
|
GS135300: alcohol preference QTL 3 (Alpq3, Published QTL Chr 9)
|
|
GS84216: alcohol consumption (Published QTL, Chr 9)
|
|
GS176236: HP:0002307 Drooling
|
|
GS128581: BECs at LORR Recovery Chr# 9
|
|
GS173147: HP:0011283 Abnormality of the metencephalon
|
|
GS84215: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS84209: morphine antinociception (Published QTL, Chr 9)
|
|
GS180802: GO:0006096 glycolysis
|
|
GS126276: pirinixic acid interacting genes (MeSH:C006253) in CTD
|
|
GS192019: GO:0006007 glucose catabolic process
|
|
GS136163: leishmaniasis resistance 17 (Lmr17, Published QTL Chr 9)
|
|
GS135239: activity response to ethanol 6 (Actre6, Published QTL Chr 9)
|
|
GS175670: HP:0007364 Aplasia/Hypoplasia of the cerebrum
|
|
GS170825: HP:0002167 Neurological speech impairment
|
|
GS199267: GO:0043234 protein complex
|
|
GS136939: vertebral trabecular bone trait 7 (Vtbt7, Published QTL Chr 9)
|
|
GS178142: GO:0004742 dihydrolipoyllysine-residue acetyltransferase activity
|
|
GS193059: GO:0044446 intracellular organelle part
|
|
GS176172: HP:0001251 Ataxia
|
|
GS135371: B.burgdorferi-associated arthritis 9 (Bbaa9, Published QTL Chr 9)
|
|
GS209564: GO:0043231 intracellular membrane-bounded organelle
|
|
GS171274: HP:0100543 Cognitive impairment
|
|
GS175981: HP:0000163 Abnormality of the oral cavity
|
|
GS188924: GO:0044724 single-organism carbohydrate catabolic process
|
|
GS198219: GO:0006631 fatty acid metabolic process
|
|
GS178708: GO:0005967 mitochondrial pyruvate dehydrogenase complex
|
|
GS193217: GO:0006086 acetyl-CoA biosynthetic process from pyruvate
|
|
GS204326: GO:0019752 carboxylic acid metabolic process
|
|
GS172516: HP:0001347 Hyperreflexia
|
|
GS204021: GO:0044707 single-multicellular organism process
|
|
GS180918: GO:0046365 monosaccharide catabolic process
|
|
GS172620: HP:0000657 Oculomotor apraxia
|
|
GS178394: GO:0016052 carbohydrate catabolic process
|
|
GS127240: Acetaminophen interacting genes (MeSH:D000082) in CTD
|
|
GS185104: GO:0019318 hexose metabolic process
|
|
GS202961: GO:0019098 reproductive behavior
|
|
GS201970: GO:0016407 acetyltransferase activity
|
|
GS208576: GO:0010510 regulation of acetyl-CoA biosynthetic process from pyruvate
|
|
GS136038: inflammatory bowel disease QTL 1 (Ibdq1, Published QTL Chr 9)
|
|
GS135618: cholesterol 10 (Chol10, Published QTL Chr 9)
|
|
GS173028: HP:0004360 Abnormality of acid-base homeostasis
|
|
GS172653: HP:0002465 Poor speech
|
|
GS170965: HP:0000153 Abnormality of the mouth
|
|
GS203594: GO:0043226 organelle
|
|
GS84214: differences in cocaine responsiveness (Published QTL, CHr 9)
|
|
GS185665: GO:0009108 coenzyme biosynthetic process
|
|
GS208734: GO:0016740 transferase activity
|
|
GS177696: GO:0051186 cofactor metabolic process
|
|
GS210002: GO:0044444 cytoplasmic part
|
|
GS171168: HP:0000234 Abnormality of the head
|
|
GS135343: atherosclerosis 29 (Ath29, Published QTL Chr 9)
|
|
GS136407: organ weight QTL 7 (Orgwq7, Published QTL Chr 9)
|
|
GS209009: GO:1901576 organic substance biosynthetic process
|
|
GS190949: GO:0009058 biosynthetic process
|
|
GS135911: G protein deficiency-induced colitis 3 (Gpdc3, Published QTL Chr 9)
|
|
GS84211: cocaine related behavior (Published QTL, Chr 9)
|
|
GS176207: HP:0003781 Excessive salivation
|
|
GS203593: GO:0043227 membrane-bounded organelle
|
|
GS207991: GO:0000003 reproduction
|
|
GS201922: GO:0019318 hexose metabolic process
|
|
GS191799: GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups
|
|
GS36222: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 30-45 min in the center in Males BXD
|
|
GS210000: GO:0044446 intracellular organelle part
|
|
GS127925: Hippocampal formation - Allen Mouse Brain Atlas
|
|
GS83965: cocaine induced activation 10 (Cocia10, Published QTL, Chr 9, MGI:3040201)
|
|
GS174131: HP:0002011 Abnormality of the central nervous system
|
|
GS202316: GO:0050789 regulation of biological process
|
|
GS194087: GO:0003674 molecular_function
|
|
GS196196: GO:0022414 reproductive process
|
|
GS177356: GO:0003674 molecular_function
|
|
GS188916: GO:0044723 single-organism carbohydrate metabolic process
|
|
GS203590: GO:0043229 intracellular organelle
|
|
GS136801: "body temperature response to dietary restriction, QTL 1" (Tbdr1, Published QTL Chr 9)
|
|
GS176245: HP:0011443 Abnormality of coordination
|
|
GS176610: HP:0003593 Infantile onset
|
|
GS210160: GO:0006086 acetyl-CoA biosynthetic process from pyruvate
|
|
GS197721: GO:0030431 sleep
|
|
GS195897: GO:0044255 cellular lipid metabolic process
|
|
GS171201: HP:0001941 Acidosis
|
|
GS176345: HP:0003128 Lactic acidosis
|
|
GS180166: GO:0008152 metabolic process
|
|
GS206091: GO:0007610 behavior
|
|
GS171832: HP:0000118 Phenotypic abnormality
|
|
GS136084: keratinocyte stem cell locus 1 (Ksc1, Published QTL Chr 9)
|
|
GS206922: GO:0051193 regulation of cofactor metabolic process
|
|
GS126445: Dehydroepiandrosterone interacting genes (MeSH:D003687) in CTD
|
|
GS183122: GO:0005975 carbohydrate metabolic process
|
|
GS207949: GO:0005996 monosaccharide metabolic process
|
|
GS175341: HP:0100755 Abnormality of salivation
|
|
GS135579: cystic fibrosis modifier QTL 2 (Cfmq2, Published QTL Chr 9)
|
|
GS136764: soft tissue heal 8 (Stheal8, Published QTL Chr 9)
|
|
GS174505: HP:0000708 Behavioural/Psychiatric Abnormality
|
|
GS205543: GO:0070013 intracellular organelle lumen
|
|
GS136024: hypothermia sensitivity (Hts, Published QTL Chr 9)
|
|
GS193812: GO:0006629 lipid metabolic process
|
|
GS195214: GO:0009987 cellular process
|
|
GS177879: GO:0005759 mitochondrial matrix
|
|
GS184452: GO:0044422 organelle part
|
|
GS135595: mean cell hemoglobin concentration QTL 2 (Chcmq2, Published QTL Chr 9)
|
|
GS176586: HP:0001270 Motor delay
|
|
GS175673: HP:0100022 Abnormality of movement
|
|
GS194104: GO:0050812 regulation of acyl-CoA biosynthetic process
|
|
GS199495: GO:0051174 regulation of phosphorus metabolic process
|
|
GS86906: Table S1: Additional data file 1 is a table listing the results of two-way ANOVA (FDR < 1%). Lists of probe sets and gene names altered by strain (3457). [DRG]
provisional
|
|
GS136379: obesity QTL 5 (Obq5, Published QTL Chr 9)
|
|
GS198263: GO:0005488 binding
|
|
GS171309: HP:0000252 Microcephaly
|
|
GS86932: Table S3: CORTEX 17K MICROARRAY [DRG]
|
|
GS175169: HP:0001317 Abnormality of the cerebellum
|
|
GS122653: Clozapine interacting genes (MeSH:D003024) in CTD
|
|
GS209235: GO:0006793 phosphorus metabolic process
|
|
GS208737: GO:0016747 transferase activity, transferring acyl groups other than amino-acyl groups
|
|
GS136673: skull morphology 12 (Skull12, Published QTL Chr 9)
|
|
GS36000: Whole Brain Gene expression correlates of Open Field Inovel TOTAL locomotion (cm in 1 hr) in the center in Males BXD
|
|
GS210357: GO:0044249 cellular biosynthetic process
|
|
GS180452: GO:0044237 cellular metabolic process
|
|
GS182469: GO:0043234 protein complex
|
|
GS129137: fecundity QTL 4 (Fecq4 Published QTL Chr 9)
|
|
GS135233: activity-distance traveled 4 (Actd4, Published QTL Chr 9)
|
|
GS1228: Expression patterns of the 77 genes that differentially expressed between brains of wild-type and nAChR beta-4 subunit deficient mice
|
|
GS195144: GO:0016052 carbohydrate catabolic process
|
|
GS180164: GO:0008150 biological_process
|
|
GS178229: GO:0071616 acyl-CoA biosynthetic process
|
|
GS176333: HP:0007319 Morphological abnormality of the central nervous system
|
|
GS193216: GO:0006085 acetyl-CoA biosynthetic process
|
|
GS180800: GO:0006090 pyruvate metabolic process
|
|
GS195465: GO:0005967 mitochondrial pyruvate dehydrogenase complex
|
|
GS205255: GO:0044238 primary metabolic process
|
|
GS180236: GO:0032991 macromolecular complex
|
|
GS135374: body length 4 (Bdln4, Published QTL Chr 9)
|
|
GS194434: GO:0051186 cofactor metabolic process
|
|
GS127930: Midbrain - Allen Mouse Brain Atlas
|
|
GS127933: Pons - Allen Mouse Brain Atlas
|
|
GS199922: GO:0005975 carbohydrate metabolic process
|
|
GS210163: GO:0006082 organic acid metabolic process
|
|
GS190954: GO:0009056 catabolic process
|
|
GS209455: GO:0003824 catalytic activity
|
|
GS177813: GO:0031974 membrane-enclosed lumen
|
|
GS184218: GO:0071704 organic substance metabolic process
|
|
GS194979: GO:0071616 acyl-CoA biosynthetic process
|
|
GS125506: Valproic Acid interacting genes (MeSH:D014635) in CTD
|
|
GS176072: HP:0006961 Jerky head movements
|
|
GS208956: GO:0006007 glucose catabolic process
|
|
GS866: Linear decrease in expression in both Pax6 (Sey) mutants and controls.
|
|
GS177219: GO:0035383 thioester metabolic process
|
|
GS34847: Striatum Gene expression correlates of Open Field Inovel TOTAL rears in the center in BXD Males
|
|
GS201949: GO:0044699 single-organism process
|
|
GS172666: HP:0011804 Abnormality of muscle physiology
|
|
GS36015: Whole Brain Gene expression correlates of Open Field Inovel TOTAL rears in the center in Males BXD
|
|
GS175107: HP:0003808 Abnormal muscle tone
|
|
GS178461: GO:0009987 cellular process
|
|
GS193061: GO:0044444 cytoplasmic part
|
|
GS192624: GO:0043231 intracellular membrane-bounded organelle
|
|
GS186743: GO:0043227 membrane-bounded organelle
|
|
GS173113: HP:0002186 Apraxia
|
|
GS180799: GO:0006091 generation of precursor metabolites and energy
|
|
GS191043: GO:0005996 monosaccharide metabolic process
|
|
GS193268: GO:0005575 cellular_component
|
|
GS172228: HP:0002194 Delayed gross motor development
|
|
GS127923: Cerebellum - Allen Mouse Brain Atlas
|
|
GS207967: GO:0030523 dihydrolipoamide S-acyltransferase activity
|
|
GS176817: HP:0011446 Abnormality of higher mental function
|
|
GS125792: Ethanol interacting genes (MeSH:D000431) in CTD
|
|
GS35975: Whole Brain Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in Females & Males BXD
|
|
GS86494: Table S1: Hippocampus 17 K microarray data. [DRG]
|
|
GS135660: cocaine related behavior 8 (Cocrb8, Published QTL Chr 9)
|
|
GS207857: GO:0009058 biosynthetic process
|
|
GS185724: GO:0043436 oxoacid metabolic process
|
|
GS197534: GO:0019320 hexose catabolic process
|
|
GS136550: proteinuria 3 (Ptnu3, Published QTL Chr 9)
|
|
GS201023: GO:0071704 organic substance metabolic process
|
|
GS126989: Hydralazine interacting genes (MeSH:D006830) in CTD
|
|
GS170964: HP:0000152 Abnormality of head and neck
|
|
GS191106: GO:0044464 cell part
|
|
GS180789: GO:0016418 S-acetyltransferase activity
|
|
GS135485: bone response to mechanical loading 5 (Brml5, Published QTL Chr 9)
|
|
GS127205: Tamoxifen interacting genes (MeSH:D013629) in CTD
|
|
GS34801: Whole Brain Gene expression correlates of Open Field Inovel TOTAL locomotion ( cm in 1 hr) in the center in Males BXD
|
|
GS136009: haloperidol-induced catelepsy 5 (Hpic5, Published QTL Chr 9)
|
|
GS204612: GO:0019222 regulation of metabolic process
|
|
GS35053: Striatum Gene expression correlates of Novel Open Field - TOTAL rears in the periphery in Males BXD
|
|
GS171453: HP:0003674 Onset
|
|
GS194555: GO:0031974 membrane-enclosed lumen
|
|
GS84210: alcohol preference QTL 1 (Alpq1 Published QTL, Chr 9)
|
|
GS84208: METH responses for home cage activity (Published QTL, Chr 9)
|
|
GS171277: HP:0100547 Abnormality of the forebrain
|
|
GS192074: GO:1901575 organic substance catabolic process
|
|
GS173146: HP:0011282 Abnormality of the hindbrain
|
|
GS83992: cocaine related behavior 8 (Cocrb8, Published QTL, Chr 9)
|
|
GS185585: GO:0044710 single-organism metabolic process
|
|
GS172134: HP:0000639 Nystagmus
|
|
GS135768: experimental allergic encephalomyelitis susceptibility 9 (Eae9, Published QTL Chr 9)
|
|
GS206696: GO:0044702 single organism reproductive process
|
|
GS191798: GO:0016746 transferase activity, transferring acyl groups
|
|
GS200310: GO:0019217 regulation of fatty acid metabolic process
|
|
GS135474: brachyury modifier 1 (Brm1, Published QTL Chr 9)
|
|
GS180737: GO:0019320 hexose catabolic process
|
|
GS84218: differences in cocaine responsiveness (Published QTL, Chr 9)
|
|
GS86977: Table S1: All transcripts significantly different in abundance between the majority of heroin subjects and their matched controls [DRG]
provisional
|
|
GS127926: Hippocampal region - Allen Mouse Brain Atlas
|
|
GS135949: HDL QTL 17 (Hdlq17, Published QTL Chr 9)
|
|
GS202415: GO:0044710 single-organism metabolic process
|
|
GS207903: GO:0044281 small molecule metabolic process
|
|
GS34840: Whole Brain Gene expression correlates of Open Field Inovel TOTAL rears in the center in Males BXD
|
|
GS197593: GO:0006091 generation of precursor metabolites and energy
|
|
GS127932: Pallidum - Allen Mouse Brain Atlas
|
|
GS185152: GO:0016407 acetyltransferase activity
|
|
GS84220: morphine antinociception (Published QTL, Chr 9)
|
|
GS194133: GO:0005737 cytoplasm
|
|
GS84212: ethanol consumption 3 (Etohc3, Published QTL, Chr 9)
|
|
GS175525: HP:0000004 Onset and clinical course
|
|
GS136809: tuberculosis severity 2 (Tbs2, Published QTL Chr 9)
|
|
GS191796: GO:0016740 transferase activity
|
|
GS184561: GO:0045254 pyruvate dehydrogenase complex
|
|
GS173079: HP:0000496 Abnormality of eye movement
|
|
GS180782: GO:0016417 S-acyltransferase activity
|
|
GS172857: HP:0004305 Involuntary movements
|
|
GS184446: GO:0044429 mitochondrial part
|
|
GS35985: Whole Brain Gene expression correlates of Open Field InovelTOTAL locomotion (activity beam breaks) in the center in Males BXD
|
|
GS177031: HP:0011442 Abnormality of central motor function
|
|
GS129130: epilepsy 4 (El4 Published QTL Chr 9)
|
|
GS136118: body length 5 (Lgth5, Published QTL Chr 9)
|
|
GS199314: GO:0006732 coenzyme metabolic process
|
|
GS173246: HP:0001332 Dystonia
|
|
GS195597: GO:0010565 regulation of cellular ketone metabolic process
|
|
GS194442: GO:0051188 cofactor biosynthetic process
|
|
GS135316: alcohol preference 5 QTL (Ap5q, Published QTL Chr 9)
|
|
GS176170: HP:0001252 Muscular hypotonia
|
|
GS187462: GO:0019752 carboxylic acid metabolic process
|
|
GS127929: Medulla - Allen Mouse Brain Atlas
|
|
GS177409: GO:0005739 mitochondrion
|
|
GS184447: GO:0044424 intracellular part
|
|
GS121837: bexarotene interacting genes (MeSH:C095105) in CTD
|
|
GS207862: GO:0009056 catabolic process
|
|
GS209863: GO:0050896 response to stimulus
|
|
GS188684: GO:0070013 intracellular organelle lumen
|
|
GS84219: cocaine related behavior (Published QTL, Chr 9)
|
|
GS175191: HP:0002060 Abnormality of the cerebrum
|
|
GS194621: GO:0005759 mitochondrial matrix
|
|
GS182475: GO:0043233 organelle lumen
|
|
GS135676: cholesterol QTL 5 (Cq5, Published QTL Chr 9)
|
|
GS210212: GO:0005575 cellular_component
|
|
GS202497: GO:0009108 coenzyme biosynthetic process
|
|
GS206623: GO:0050794 regulation of cellular process
|
|
GS193945: GO:0035384 thioester biosynthetic process
|
|
GS136140: lithogenic gene 20 (Lith20, Published QTL Chr 9)
|
|
GS197596: GO:0006096 glycolysis
|
|
GS176801: HP:0001263 Global developmental delay
|
|
GS174500: HP:0000707 Abnormality of the nervous system
|
|
GS171998: HP:0001939 Abnormality of metabolism/homeostasis
|
|
GS210180: GO:0031326 regulation of cellular biosynthetic process
|
|
GS206920: GO:0051196 regulation of coenzyme metabolic process
|
|
GS210159: GO:0006085 acetyl-CoA biosynthetic process
|
|
GS182834: GO:0005623 cell
|
|
GS205622: GO:0009889 regulation of biosynthetic process
|
|
GS174914: HP:0003011 Abnormality of the musculature
|
|
GS36227: Whole Brain Gene expression correlates of Novel environment locomotion (activity beam breaks) 45-60 min in the center in Females & Males BXD
|
|
GS196943: GO:0008152 metabolic process
|
|
GS136756: susceptibility to Salmonella typhimurium antigens 7 (Ssta7, Published QTL Chr 9)
|
|
GS192018: GO:0006006 glucose metabolic process
|
|
GS176166: HP:0001256 Intellectual disability, mild
|
|
GS199634: GO:0005623 cell
|
|
GS34735: Striatum Gene expression correlates of Novel environment rears 30-45 min in the periphery in Males BXD
|
|
GS210182: GO:0031323 regulation of cellular metabolic process
|
|
GS135821: ethanol consumption 3 (Etohc3, Published QTL Chr 9)
|
|
GS136841: T lymphocyte fraction 2 (Tlf2, Published QTL Chr 9)
|
|
GS176613: HP:0000271 Abnormality of the face
|
|
GS175928: HP:0000240 Abnormality of skull size
|